Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cells.
about
The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergyMicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemiaIbrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axisCXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood.In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host diseaseChronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients.The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study.Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK.AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cellsCo-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivoTLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.Treatment with Ibrutinib Inhibits BTK- and VLA-4-Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo.IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functionsInter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial."Role of the B-cell receptor and the microenvironment in chronic lymphocytic leukemia''.Does B cell receptor signaling in chronic lymphocytic leukaemia cells differ from that in other B cell types?Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation.IL-4 rescues surface IgM expression in chronic lymphocytic leukemia.Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming.Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells.Higher levels of reactive oxygen species are associated with anergy in chronic lymphocytic leukemia.Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia.Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.TNF receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin.Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein.Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands?Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade.Activation of the PI3K/AKT pathway by microRNA-22 results in CLL B-cell proliferation.Critical molecular pathways in CLL therapy.Chronic lymphocytic leukaemia
P2860
Q26865760-002B371C-EFA5-45C9-86F8-8644E599295EQ28241703-B543F041-6F86-47F3-B515-1B4AC46C5519Q28277551-9E1ECB49-DDAE-4D34-AB1F-60AF332B0890Q30657004-EB66FDF9-61AB-43C8-B330-5267F6C2E904Q33774491-DACF6F8B-580B-409B-A4C7-62A91B1F7195Q33798249-70004B00-382A-41A9-8194-CCCDC135EAA6Q33934606-CC976E41-60E6-430F-91B8-7275262CEB4EQ34037828-BE71B51B-C050-4840-B85F-E571E57DE48CQ34097631-3FFAF780-7738-4F6F-B19A-5FDD31165510Q34289493-22ABC98C-5F79-4E81-AD40-0DEA07B379CEQ34508337-BDAFA315-67FD-43CA-94A0-E22C58C9C044Q34770449-8B076DC0-09F7-49F6-AB6F-02AF35B1B674Q35781372-471B63B2-56BA-4473-B57D-CAFC38E9FFF5Q35861964-AC3845DF-B929-4516-B7A8-21E190082D8BQ36172601-9DEDDA5E-0D64-4127-BA02-47728926848AQ36462397-41F4EDDA-7FD5-478A-9B47-1D245863FFAAQ36520447-82557264-3CDA-423B-9B55-BA72113BCF7CQ37199470-BBA5997F-ABA4-44AA-8451-83BA725A1818Q38140625-D3423E5C-64EF-48E3-9A7E-8CA808BD345EQ38237648-9160232A-051F-4DE1-AC4F-7D791DE8A9D3Q38749775-914E1B22-D3B2-4053-ADAF-221934BD9906Q38768397-054F6961-C972-411D-B75C-B5078C8AF894Q39432317-CCF51D12-FE3D-448B-AA82-8F1BF4E9486DQ41947180-AE916CF9-25FB-437E-B9C4-C502C17E7BADQ42272463-F5A696FA-1A96-4990-ADEE-B03549B4D73DQ42384520-5B1CF51F-6CF3-4561-8C8A-5E18C6CBA282Q48307279-54870630-4F15-418A-8D91-9C90B2371B17Q49912101-2C417E05-57E7-4EF4-BAFF-47FA4C701AD6Q50078371-D270DE9E-E378-491A-9D44-94AA830DDC41Q51749083-2B5DFCBB-C3DB-4486-B4E2-5B78072DD0DEQ52930409-478A7116-87F1-4E97-B789-78B5EFCD4FC3Q53071978-A65D6AD0-7E47-4FD4-9A45-7A8E9C62DBA9Q54352918-AA6050C1-9739-428F-8A11-E27A692F8160Q55447785-18798EB2-D869-488F-A0F3-008A280ED068Q56270980-9F6E255D-600B-4150-B9DE-F52C8B858868
P2860
Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Intraclonal complexity in chro ...... ded and older/quiescent cells.
@ast
Intraclonal complexity in chro ...... ded and older/quiescent cells.
@en
type
label
Intraclonal complexity in chro ...... ded and older/quiescent cells.
@ast
Intraclonal complexity in chro ...... ded and older/quiescent cells.
@en
prefLabel
Intraclonal complexity in chro ...... ded and older/quiescent cells.
@ast
Intraclonal complexity in chro ...... ded and older/quiescent cells.
@en
P2093
P2860
P1433
P1476
Intraclonal complexity in chro ...... ded and older/quiescent cells.
@en
P2093
Carlo Calissano
Claire Emson
Cristina Sison
Elizabeth J Murphy
Gregory Hayes
Igor M Dozmorov
Ivana Ivanovic
Jonathan E Kolitz
Kanti R Rai
Marc K Hellerstein
P2860
P2888
P304
P356
10.2119/MOLMED.2011.00360
P407
P577
2011-09-23T00:00:00Z
P5875
P6179
1068965464